Scientists hunt for a new target to fight Pre-Leukemia
NCT ID NCT07455500
Summary
This study aims to gather information to see if a protein on certain blood cancer cells, called IL-1RAP, could be a good target for a future CAR-T cell therapy. Researchers will collect blood and bone marrow samples from 120 patients with myelodysplastic syndromes (MDS), a type of pre-leukemia. They will test in the lab if specially engineered immune cells can attack MDS cells using this protein as a target.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MYELODYSPLASTIC SYNDROME are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.